electroCore, Inc.
NASDAQ:ECORMedical - Devices
-$0.50 today
- Market cap
- $71.13M
- Beta
- 0.87
- P/E (TTM)
- -4.8
- EPS (TTM)
- -$1.72
Volume 0.06M
Average 0.11M
ECOR Revenue
Total income from selling goods and services before any costs are deducted; the top line of the income statement.
electroCore, Inc.NASDAQ: ECOR
Revenue · Q1 FY2026 · quarter ended Mar 2026
Revenue growth accelerates
Q1 FY2026 revenue of $9.58M rose 42.6% year over year, ahead of the +31.9% change in trailing-twelve-month revenue. Sequentially, it rose 3.7% from the prior quarter. Over 3 fiscal years it compounded at +55.1% a year.
Context
- Revenue increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether revenue reaches the consensus estimate from 4 analysts of $41.92M (+30.9%) for the fiscal year ending Dec 2026, a step up from the +27.2% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- $9.58M+3.7% QoQ
- Last fiscal yearDec 2025
- $32.03M+27.2% YoY
- LTMMar 2026
- $34.9M+31.9% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +42.6% | +28.6% | -14.0 pp |
| 1 year | +27.2% | +30.9% | +3.7 pp |
| 3-year CAGR | +55.1% | +29.1% | -26.0 pp |
| 5-year CAGR | +22.5% | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Revenue history
USD · from the income statement
- Latest · FY2025
- 32.03M USD
- Year-over-year change
- +27.2%
- 4-year CAGR
- +55.7%
| Period | Period end | Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 32.03M | +27.2% |
| FY2024 | 2024-12-31 | 25.18M | +57.1% |
| FY2023 | 2023-12-31 | 16.03M | +86.6% |
| FY2022 | 2022-12-31 | 8.59M | +57.6% |
| FY2021 | 2021-12-31 | 5.45M | — |
Revenue vs competitors
How ECOR compares with its peers on the latest reported figures
- ECOR's LTM Mar 2026 revenue of $34.9M is the 2nd highest of the 6 companies compared; the peer median is $1.4M.
- Its year-over-year change of +31.9% is the 3rd highest of 4, against a peer median of +520.4%.
- Over three fiscal years its annual growth of +55.1% compares with a peer median of +38.1%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Mar 2026 | $41.21M | +6.7% | +38.1% | |
| LTM Mar 2026 | $34.9M | +31.9% | +55.1% | |
| LTM Mar 2026 | $1.49M | +520.4% | — | |
| LTM Jun 2026 | $1.4M | +3052.0% | — | |
| LTM Mar 2026 | $0 | — | — | |
| LTM Mar 2026 | $0 | — | — | |
| Peer median (excluding ECOR) | $1.4M | +520.4% | +38.1% | |
Competitors are the stored peer set for ECOR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 5.45M | 8.59M | 16.03M | 25.18M | 32.03M |
| Cost of Revenue | 1.39M | 1.62M | 2.8M | 3.79M | 4.24M |
| Gross Profit | 4.07M | 6.98M | 13.23M | 21.4M | 27.79M |
| Gross Margin | 74.6% | 81.2% | 82.5% | 85.0% | 86.8% |
| Research & Development | 2.54M | 5.52M | 5.32M | 2.36M | 2.74M |
| Selling, General & Admin | 21.57M | 24.33M | 26.71M | 31.2M | 38.21M |
| Operating Expenses | 24.11M | 29.85M | 32.03M | 33.56M | 40.94M |
| Depreciation & Amortization | 382K | 596K | 1.26M | 1.26M | 1.68M |
| EBITDA | (17.69M) | (22M) | (17.76M) | (10.72M) | (11.7M) |
| EBITDA Margin | -324.5% | -256.0% | -110.8% | -42.6% | -36.5% |
| Operating Income | (20.04M) | (22.87M) | (18.81M) | (12.16M) | (13.15M) |
| Operating Margin | -367.7% | -266.2% | -117.3% | -48.3% | -41.1% |
| Interest Income | 11K | 287K | 433K | 572K | 298K |
| Interest Expense | 0 | 0 | 0 | 0 | 590K |
| Other Income / Expenses | 1.97M | 281K | (215K) | 183K | (810K) |
| Income Before Tax | (18.07M) | (22.59M) | (19.02M) | (11.98M) | (13.96M) |
| Pre-Tax Margin | -331.5% | -263.0% | -118.7% | -47.6% | -43.6% |
| Income Tax Expense | (851K) | (431K) | (186K) | (93K) | 3K |
| Net Income | (17.22M) | (22.16M) | (18.83M) | (11.89M) | (13.97M) |
| Net Margin | -315.9% | -257.9% | -117.5% | -47.2% | -43.6% |
| EPS (Basic) | (4.36) | (4.69) | (3.42) | (1.59) | (1.65) |
| EPS (Diluted) | (4.36) | (4.69) | (3.42) | (1.59) | (1.65) |
| Weighted Avg Shares | 3.95M | 4.73M | 5.52M | 7.48M | 8.48M |
| Weighted Avg Shares (Diluted) | 3.95M | 4.73M | 5.52M | 7.48M | 8.48M |
electroCore, Inc.
NASDAQ:ECOR
Intrinsic Alpha fair value
Locked
Current Price
$7.71
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.